Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer

Ruo Kai Lin, Han Shui Hsu, Jer Wei Chang, Chih Yi Chen, Jung Ta Chen, Yi Ching Wang

研究成果: 雜誌貢獻文章

170 引文 (Scopus)

摘要

Overexpression of DNA methyltransferases DNMT1, DNMT3a and DNMT3b has been reported in various cancers. However, physical binding of DNA methyltransferase (DNMT) to the hypermethylated promoter of tumor suppressor genes (TSGs) has never been demonstrated in tumor tissues. In addition, alteration of DNMT at the protein level has never been reported in the same series of cancer patients. By immunohistochemical analysis, we demonstrated that DNMT1, DNMT3a and DNMT3b proteins were highly expressed in a coordinate manner in lung tumors, particularly in smokers (P = 0.037, by the Fisher exact test). Patients with DNMT1 overexpression had a trend of poorer prognosis than those without such overexpression, and this prognostic significance was apparent in squamous carcinoma (SQ) patients (P = 0.041, by the log-rank test). Both DNMT1 and DNMT3b overexpressions correlated with hypermethylation in the TSG promoters, especially among smoking SQ patients (P = 0.012). To further explore the molecular mechanisms between altered TSGs promoter methylation and overexpression of DNMTs protein, we performed a tissue chromatin-immunoprecipitation polymerase chain reaction assay for lung tumors and showed that the methylated FHIT, p16INK4a and RARβ promoters were bound by both DNMT protein and methyl-CpG-binding protein 2. These data suggest that overexpression and strong binding of various DNMTs may result in promoter hypermethylation of multiple TSGs and ultimately lead to lung tumorigenesis and poor prognosis.

原文英語
頁(從 - 到)205-213
頁數9
期刊Lung Cancer
55
發行號2
DOIs
出版狀態已發佈 - 二月 2007
對外發佈Yes

指紋

Methyltransferases
Methylation
Lung Neoplasms
Tumor Suppressor Genes
Protein Methyltransferases
DNA
Neoplasms
Lung
Methyl-CpG-Binding Protein 2
Chromatin Immunoprecipitation
Squamous Cell Carcinoma
Carcinogenesis
Proteins
Smoking
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Oncology

引用此文

Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. / Lin, Ruo Kai; Hsu, Han Shui; Chang, Jer Wei; Chen, Chih Yi; Chen, Jung Ta; Wang, Yi Ching.

於: Lung Cancer, 卷 55, 編號 2, 02.2007, p. 205-213.

研究成果: 雜誌貢獻文章

Lin, Ruo Kai ; Hsu, Han Shui ; Chang, Jer Wei ; Chen, Chih Yi ; Chen, Jung Ta ; Wang, Yi Ching. / Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer. 於: Lung Cancer. 2007 ; 卷 55, 編號 2. 頁 205-213.
@article{203463212c2c46d396e7b01d6f8b77c4,
title = "Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer",
abstract = "Overexpression of DNA methyltransferases DNMT1, DNMT3a and DNMT3b has been reported in various cancers. However, physical binding of DNA methyltransferase (DNMT) to the hypermethylated promoter of tumor suppressor genes (TSGs) has never been demonstrated in tumor tissues. In addition, alteration of DNMT at the protein level has never been reported in the same series of cancer patients. By immunohistochemical analysis, we demonstrated that DNMT1, DNMT3a and DNMT3b proteins were highly expressed in a coordinate manner in lung tumors, particularly in smokers (P = 0.037, by the Fisher exact test). Patients with DNMT1 overexpression had a trend of poorer prognosis than those without such overexpression, and this prognostic significance was apparent in squamous carcinoma (SQ) patients (P = 0.041, by the log-rank test). Both DNMT1 and DNMT3b overexpressions correlated with hypermethylation in the TSG promoters, especially among smoking SQ patients (P = 0.012). To further explore the molecular mechanisms between altered TSGs promoter methylation and overexpression of DNMTs protein, we performed a tissue chromatin-immunoprecipitation polymerase chain reaction assay for lung tumors and showed that the methylated FHIT, p16INK4a and RARβ promoters were bound by both DNMT protein and methyl-CpG-binding protein 2. These data suggest that overexpression and strong binding of various DNMTs may result in promoter hypermethylation of multiple TSGs and ultimately lead to lung tumorigenesis and poor prognosis.",
keywords = "5′CpG hypermethylation, DNMT, Immunohistochemistry, MeCP2, NSCLC, Tissue chromatin immunoprecipitation",
author = "Lin, {Ruo Kai} and Hsu, {Han Shui} and Chang, {Jer Wei} and Chen, {Chih Yi} and Chen, {Jung Ta} and Wang, {Yi Ching}",
year = "2007",
month = "2",
doi = "10.1016/j.lungcan.2006.10.022",
language = "English",
volume = "55",
pages = "205--213",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer

AU - Lin, Ruo Kai

AU - Hsu, Han Shui

AU - Chang, Jer Wei

AU - Chen, Chih Yi

AU - Chen, Jung Ta

AU - Wang, Yi Ching

PY - 2007/2

Y1 - 2007/2

N2 - Overexpression of DNA methyltransferases DNMT1, DNMT3a and DNMT3b has been reported in various cancers. However, physical binding of DNA methyltransferase (DNMT) to the hypermethylated promoter of tumor suppressor genes (TSGs) has never been demonstrated in tumor tissues. In addition, alteration of DNMT at the protein level has never been reported in the same series of cancer patients. By immunohistochemical analysis, we demonstrated that DNMT1, DNMT3a and DNMT3b proteins were highly expressed in a coordinate manner in lung tumors, particularly in smokers (P = 0.037, by the Fisher exact test). Patients with DNMT1 overexpression had a trend of poorer prognosis than those without such overexpression, and this prognostic significance was apparent in squamous carcinoma (SQ) patients (P = 0.041, by the log-rank test). Both DNMT1 and DNMT3b overexpressions correlated with hypermethylation in the TSG promoters, especially among smoking SQ patients (P = 0.012). To further explore the molecular mechanisms between altered TSGs promoter methylation and overexpression of DNMTs protein, we performed a tissue chromatin-immunoprecipitation polymerase chain reaction assay for lung tumors and showed that the methylated FHIT, p16INK4a and RARβ promoters were bound by both DNMT protein and methyl-CpG-binding protein 2. These data suggest that overexpression and strong binding of various DNMTs may result in promoter hypermethylation of multiple TSGs and ultimately lead to lung tumorigenesis and poor prognosis.

AB - Overexpression of DNA methyltransferases DNMT1, DNMT3a and DNMT3b has been reported in various cancers. However, physical binding of DNA methyltransferase (DNMT) to the hypermethylated promoter of tumor suppressor genes (TSGs) has never been demonstrated in tumor tissues. In addition, alteration of DNMT at the protein level has never been reported in the same series of cancer patients. By immunohistochemical analysis, we demonstrated that DNMT1, DNMT3a and DNMT3b proteins were highly expressed in a coordinate manner in lung tumors, particularly in smokers (P = 0.037, by the Fisher exact test). Patients with DNMT1 overexpression had a trend of poorer prognosis than those without such overexpression, and this prognostic significance was apparent in squamous carcinoma (SQ) patients (P = 0.041, by the log-rank test). Both DNMT1 and DNMT3b overexpressions correlated with hypermethylation in the TSG promoters, especially among smoking SQ patients (P = 0.012). To further explore the molecular mechanisms between altered TSGs promoter methylation and overexpression of DNMTs protein, we performed a tissue chromatin-immunoprecipitation polymerase chain reaction assay for lung tumors and showed that the methylated FHIT, p16INK4a and RARβ promoters were bound by both DNMT protein and methyl-CpG-binding protein 2. These data suggest that overexpression and strong binding of various DNMTs may result in promoter hypermethylation of multiple TSGs and ultimately lead to lung tumorigenesis and poor prognosis.

KW - 5′CpG hypermethylation

KW - DNMT

KW - Immunohistochemistry

KW - MeCP2

KW - NSCLC

KW - Tissue chromatin immunoprecipitation

UR - http://www.scopus.com/inward/record.url?scp=33846111256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846111256&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2006.10.022

DO - 10.1016/j.lungcan.2006.10.022

M3 - Article

C2 - 17140695

AN - SCOPUS:33846111256

VL - 55

SP - 205

EP - 213

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 2

ER -